Completed PHASE4 INTERVENTIONAL 2-arm NCT02299232

Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation (DEX)

Comparison of Two Different Intranasal Doses of Dexmedetomidine in Children for Magnetic Resonance Imaging (MRI) Sedation

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital

Conditions Anesthesia

Interventions Dexmedetomidine

Updated 6 times since 2017 Last updated: Oct 24, 2017 Started: Feb 28, 2014 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02299232, this PHASE4 trial focuses on Anesthesia and remains completed. Sponsored by Sisli Hamidiye Etfal Training and Research Hospital, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Completed PHASE4

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sisli Hamidiye Etfal Training and Research Hospital

Data source: Sisli Hamidiye Etfal Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.